Purple Biotech (PPBT) Net Income (2014 - 2026)
Purple Biotech's (PPBT) quarterly Net Income came in at -$89000.0 in Q1 2026, up 80.48% year-on-year from -$49312.3 in Q1 2025, and up 99.62% on a QoQ basis from -$23.6 million in Q4 2025.
Purple Biotech (PPBT) Net Income (2014 - 2026) Analysis & Trends
Purple Biotech (PPBT) has 13 years of Net Income data on file, last reported at -$89000.0 in Q1 2026.
- On a quarterly basis, Net Income rose 80.48% year-over-year to -$89000.0 in Q1 2026; TTM through Mar 2026 was -$26.1 million, a 560.72% decrease from a year earlier, with the FY2025 full-year figure at -$26.5 million, down 263.95% from the prior year.
- Net Income for Q1 2026 stood at -$89000.0, up from -$23.6 million in the prior quarter.
- Over the last five years, Net Income for PPBT reached as high as $15.1 million in Q4 2023 and fell as low as -$23.6 million in Q4 2025.
- Historically, Net Income has averaged -$2.6 million across 5 years, with a median of -$2.4 million in 2024.
- On a YoY basis, Net Income climbed as much as 1089.57% in 2022 and fell as far as 177500.0% in 2022.
- Year by year, Net Income stood at $6.0 million in 2022, then surged by 149.84% to $15.1 million in 2023, then sank by 102.75% to -$415000.0 in 2024, then sank by 5596.87% to -$23.6 million in 2025, then soared by 99.62% to -$89000.0 in 2026.
- Per Business Quant data, the three most recent Net Income figures were -$89000.0 in Q1 2026, -$23.6 million in Q4 2025, and -$1.3 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -37.09 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 227.36 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -3.31 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 1.03 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 727.20 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | -26.94 Mn |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 362.00 Mn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -453.82 Mn |
| 10 | Purple Biotech | 1.33 Bn | 1.33 Bn | - | -89,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -89,000.00 |
| Dec 31, 2025 | -23.64 Mn |
| Sep 30, 2025 | -1.31 Mn |
| Jun 30, 2025 | -1.09 Mn |
| Mar 31, 2025 | -456,000.00 |
| Dec 31, 2024 | -415,000.00 |
| Sep 30, 2024 | -668,000.00 |
| Jun 30, 2024 | -2.42 Mn |
| Mar 31, 2024 | -3.78 Mn |
| Dec 31, 2023 | 15.10 Mn |
| Sep 30, 2023 | -5.06 Mn |
| Jun 30, 2023 | -5.16 Mn |
| Mar 31, 2023 | -4.90 Mn |
| Dec 31, 2022 | 6.04 Mn |
| Sep 30, 2022 | -4.85 Mn |
| Jun 30, 2022 | -3.55 Mn |
| Mar 31, 2022 | -7.32 Mn |
| Dec 31, 2021 | 508,000.00 |
| Sep 30, 2021 | 154,000.00 |
| Jun 30, 2021 | -2,000.00 |